PALOMA PHARMACEUTICALS
Paloma Pharmaceuticals, Inc. is an early stage drug development company focusing on pathologies showing an aberrant up-regulation of the PI3K/Akt/mTOR pathway including cancer, ocular diseases (macular degeneration and diabetic retinopathy), arthritis, fibrotic diseases (renal and pulmonary fibrosis), CNS (epilepsy and neurodegenerative diseases), antiviral (HIV/AIDS) and skin diseases (psoriasis, atopic dermatitis and photodamage/wrinkling).
PALOMA PHARMACEUTICALS
Industry:
Biotechnology Health Diagnostics Pharmaceutical
Founded:
2005-01-01
Address:
Jamaica Plain, Massachusetts, United States
Country:
United States
Website Url:
http://www.palomapharma.com
Total Employee:
1+
Status:
Active
Contact:
6174076314
Email Addresses:
[email protected]
Total Funding:
1.7 M USD
Technology used in webpage:
SPF Amazon AWS Global Accelerator
Similar Organizations
Celator Pharmaceuticals
Celator Pharmaceuticals is a biopharmaceutical company developing therapies to treat cancer, using the drug ratio technology platform.
NephroDI Therapeutics
NephroDI Therapeutics is a biopharmaceutical company that focuses on the concentration disorders of the kidney.
Reverse Medical
Reverse Medical is a commercial-stage medical device company focused on revascularizing patients who experience acute ischemic strokes.
Founder
Official Site Inspections
http://www.palomapharma.com
- Host name: a2aa9ff50de748dbe.awsglobalaccelerator.com
- IP address: 15.197.148.33
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Paloma Pharmaceuticals"
Paloma Pharmaceuticals - Crunchbase Company Profile & Funding
Contact Email [email protected] Phone Number 6174076314 Paloma Pharmaceuticals, Inc. is an early stage drug development company focusing on pathologies showing an โฆSee details»
Paloma Pharmaceuticals - Org Chart, Teams, Culture
View Paloma Pharmaceuticals' up-to-date org chart, open roles, and culture details. Find executives, board members, teams, related companies, and more.See details»
Paloma Pharmaceuticals, Inc. - Drug pipelines, Patents, Clinical โฆ
Explore Paloma Pharmaceuticals, Inc. with its drug pipeline, therapeutic area, technology platform, 1 clinical trial, 2 news, and 6 literature, Drug:Palomids.See details»
Paloma Pharmaceuticals Inc - Company Profile and News
Company profile page for Paloma Pharmaceuticals Inc including stock price, company news, executives, board members, and contact informationSee details»
Organization | Paloma Pharmaceuticals, Inc.
Organization Overview. First Clinical Trial. 2010 NCT01033721. First Marketed Drug. None First NDA Approval. None Last Known Activity. 2021 Timeline < Back; View all... NOW. Now; Active โฆSee details»
Paloma Pharmaceuticals, Inc. - Jamaica Plain, USA
Feb 9, 2010 palomapharma.com +1617522-7681. Share. Xing Linkedin Facebook X E-mail Loading... Bookmark. Bookmark list; Bookmark. Paloma Pharmaceuticals, Inc. 37 Neillian โฆSee details»
Paloma Pharmaceuticals - Products, Competitors, Financials, โฆ
About Paloma Pharmaceuticals. Paloma Pharmaceuticals, Inc. is a drug development company focusing on pathologies with a vascular component including cancer, ocular diseases (macular โฆSee details»
Paloma Pharmaceuticals, Inc.:Company Profile & Technical โฆ
Paloma Pharmaceuticals, Inc. is a company that provides Lampalizumab, Angiogenesis inhibitor, Medicine and more. Paloma Pharmaceuticals, Inc. is headquartered in United States โฆSee details»
Paloma Pharmaceuticals - Ownership and Business Overview
Apr 1, 2014 Out of 60 sectors in the Mergr database, life science ranked 9 in number of deals in 2014.The largest life science acquisition in 2014 was InterMune - which was acquired by โฆSee details»
Paloma Pharmaceuticals - PitchBook
Paloma Pharmaceuticals General Information Description. Producer of pharmaceutical drugs. The company owns intellectual property relating to a series of novel, proprietary and small โฆSee details»
Paloma Pharmaceuticals, Inc. - Company Information
Find useful insights on Paloma Pharmaceuticals, Inc.'s company details, tech stack, news alerts, competitors and more. Use 6sense to connect with top decision-makers at Paloma โฆSee details»
Paloma Pharmaceuticals, Inc. (Paloma Pharmaceuticals, Inc.) - ่ฏ็ฉ โฆ
Palomapharma.com. ๆดๆฐไบ๏ผ2024-11-04. ... Tousi has spent nearly a decade at Illumina, where she currently leads the global commercial organization. Tousi has been with Illumina since โฆSee details»
www.palomapharma.com
Www.palomapharma.comSee details»
Paloma Pharmaceuticals, Inc.: Drug pipelines, Patents, Clinical trials ...
Explore Paloma Pharmaceuticals, Inc. with its drug pipeline, therapeutic area, technology platform, 1 clinical trial, 3 news, and 1 literature.See details»
Paloma Pharmaceuticals Culture | Comparably
Learn about Paloma Pharmaceuticals' culture, see what work's like, read reviews, and find job opportunities.See details»
Paloma - Company Profile - Tracxn
Dec 21, 2024 Paloma - Provider of diagnostic kit to manage hypothyroidism in individuals. Raised a total funding of $2.5M over 1 round from 12 investors. Founded by Guillaume Cohen โฆSee details»
Paloma Pharmaceuticals - CB Insights
Explore {Paloma Pharmaceuticals's key management people. Discover current leadership team members including founders, CEO, other executives and board directors.See details»
Data and product approach as the core of Paloma Healthโs growth โฆ
Committed to 25 million Americans dealing with Hypothyroidism, Paloma Health is facilitating the access to expert and personalized treatment for this chronic condition โ all from the comfort of โฆSee details»
First results from late-breaking Phase 3 PALOMA-3 study show โฆ
CHICAGO (May 31, 2024) โ Johnson & Johnson announced today first data from the Phase 3 PALOMA-3 study evaluating subcutaneous (SC) amivantamab combined with lazertinib in โฆSee details»
PALOMA-2 and PALOMA-3: Time to Chemotherapy on Palbociclib
Jun 22, 2022 Time-to-chemotherapy results of the PALOMA-2 and -3 trials in HR+/HER2- metastatic breast cancer, which combined frontline palbociclib and endocrine therapy.See details»